AbbVie to Acquire Allergan

Posted By American Med Spa Association, Tuesday, June 25, 2019

AbbVie Inc. and Allergan plc announced that the companies have entered into a definitive transaction agreement under which AbbVie will acquire Allergan in a cash and stock transaction for a transaction equity value of approximately $63 billion, based on the closing price of AbbVie's common stock of $78.45 on June 24, 2019.
Read more at PR Newswire >>